Related Experiment Video

Updated: Jul 4, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Delivery of small interfering RNA. A review and an example of application to a junction oncogene

Anne-Laure Ramon1, Jean-Rémi Bertrand, Claude Malvy

  • 1CNRS UMR 8121, Université Paris-Sud, Institut Gustave Roussy Villejuif, France.

Tumori
|June 21, 2008
PubMed

Insights

RNA interference and antisense oligonucleotides show promise for targeting oncogenes in cancer. Innovative delivery methods are crucial for their therapeutic application in treating cancers like papillary thyroid carcinoma.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • RNA interference (RNAi) using small interfering RNA (siRNA) is a significant biological discovery.
  • Antisense oligonucleotides (ASOs) are another promising nucleic acid-based technology.
  • Both siRNA and ASOs offer potential for targeted gene silencing.

Purpose of the Study:

  • To investigate the potential of siRNA and ASOs in targeting junction oncogenes.
  • To highlight the importance of effective delivery methods for these nucleic acid therapeutics.
  • To explore their application in cancer treatment, using papillary thyroid carcinoma as a model.

Main Methods:

  • Focus on targeting junction oncogenes with siRNA and ASOs.
  • Utilizing papillary thyroid carcinoma as a model system for investigation.
  • Reviewing and emphasizing innovative delivery strategies for nucleic acid-based therapies.

Main Results:

  • siRNA and ASOs are potent tools for targeting oncogenes.
  • Effective delivery systems significantly enhance the efficiency of siRNA and ASOs.
  • These technologies, when delivered effectively, represent a powerful new therapeutic approach for cancer.

Conclusions:

  • Targeting oncogenes with siRNA and ASOs holds significant therapeutic promise for cancer.
  • The development of advanced delivery methods is critical for realizing the full potential of these nucleic acid therapies.
  • Innovative delivery systems can transform siRNA and ASOs into effective tools for cancer treatment.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...